Evidence map›Paper›PMID 32441921›Full record

ArticleACS nano2020

Super-Resolution Fluorescence Imaging Reveals That Serine Incorporator Protein 5 Inhibits Human Immunodeficiency Virus Fusion by Disrupting Envelope Glycoprotein Clusters.

Yen-Cheng Chen, Chetan Sood, Mariana Marin, Jesse Aaron, Enrico Gratton, Khalid Salaita, Gregory B Melikyan

Open access · greenAbstract read
In one paragraph

Article in ACS nano, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. SERINC4 is dispensable for male fertility and spermatogenesis in mice.American journal of translational research · 2025
    Article
  7. Article
  8. Review
  9. SERINC5 counters retroviruses and non-retroviruses.Frontiers in cellular and infection microbiology · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. HIV-1 restriction by SERINC5.Medical microbiology and immunology · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Yen-Cheng ChenDepartment of Pediatrics, Emory University School of Medicine, Atlanta, Georgia 30322, United States.
Chetan SoodDepartment of Pediatrics, Emory University School of Medicine, Atlanta, Georgia 30322, United States.
Mariana MarinDepartment of Pediatrics, Emory University School of Medicine, Atlanta, Georgia 30322, United States.
Jesse AaronJanelia Research Campus, Ashburn, Virginia 20147, United States.
Enrico GrattonLaboratory for Fluorescence Dynamics, University of California Irvine, Irvine, California 92617, United States.
Khalid SalaitaDepartment of Chemistry, Emory University, Atlanta, Georgia 30322, United States.ORCID 0000-0003-4138-3477
Gregory B MelikyanDepartment of Pediatrics, Emory University School of Medicine, Atlanta, Georgia 30322, United States.ORCID 0000-0001-5385-3013
Emory University · USFluor (United States) · USJanelia Research Campus · US

Funding

TRD4: Phasor analysisP41GM103540 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI GRATTON, ENRICO · 2012 to 2020
$12.5M
BIOPHYSICS OF PROTEIN-MEDIATED MEMBRANE FUSIONR01GM054787 · NIGMS · UNIVERSITY OF MD BIOTECHNOLOGY INSTITUTE · PI MELIKIAN, GREGORY B · 2000 to 2018
$6.5M
Biophysics of Protein-Mediated Membrane FusionR37AI150453 · NIAID · EMORY UNIVERSITY · PI Gregory B Melikian · 2020 to 2026
$4.1M
Biophysics of Protein-Mediated Membrane FusionR01AI150453 · NIAID · EMORY UNIVERSITY · PI MELIKIAN, GREGORY B · 2019 to 2019
$466k
BIOPHYSICS OF PROTEIN MEDIATED MEMBRANE FUSIONR29GM054787 · NIGMS · RUSH UNIVERSITY MEDICAL CENTER · PI MELIKIAN, GREGORY B · 1996 to 1999
–
NIAID NIH HHS R01 AI150453NIAID NIH HHS R37 AI150453NIGMS NIH HHS P41 GM103540NIGMS NIH HHS R01 GM054787NIGMS NIH HHS R29 GM054787
6 · The paper itself

Abstract

Serine incorporator protein 5 (SERINC5) is the host antiretroviral factor that reduces HIV-1 infectivity by incorporating into virions and inhibiting the envelope glycoprotein (Env) mediated virus fusion with target cells. We and others have shown that SERINC5 incorporation into virions alters the Env structure and sensitizes the virus to broadly neutralizing antibodies targeting cryptic Env epitopes. We have also found that SERINC5 accelerates the loss of Env function over time compared to control viruses. However, the exact mechanism by which SERINC5 inhibits HIV-1 fusion is not understood. Here, we utilized 2D and 3D super-resolution microscopy to examine the effect of SERINC5 on the distribution of Env glycoproteins on single HIV-1 particles. We find that, in agreement with a previous report, Env glycoproteins form clusters on the surface of mature virions. Importantly, incorporation of SERINC5, but not SERINC2, which lacks antiviral activity, disrupted Env clusters without affecting the overall Env content. We also show that SERINC5 and SERINC2 also form clusters on single virions. Unexpectedly, Env and SERINC molecules exhibited poor codistribution on virions, as evidenced by much greater Env-SERINC pairwise distances compared to Env-Env distances. This observation is inconsistent with the previously reported interaction between Env and SERINC5 and suggests an indirect effect of SERINC5 on Env cluster formation. Collectively, our results reveal a multifaceted mechanism of SERINC5-mediated restriction of HIV-1 fusion that, aside from the effects on individual Env trimers, involves disruption of Env clusters, which likely serve as sites of viral fusion with target cells.

Indexed as

HIV InfectionsMembrane ProteinsGlycoproteinsHumansOptical ImagingSerineGlycoproteinsMembrane ProteinsSERINC2 protein, humanSERINC5 protein, humanSerineDBSCANenvelope glycoprotein clusteringHIV-1 restrictionSERINC5super-resolution microscopyviral fusion

Identifiers

PMID32441921
PMCPMC8274448
OpenAlexW3027365118

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.